Skip to main content

Table 1 Clinical characteristics of the study population

From: Functional and quantitative evaluation of the 20S proteasome in serum and intracellular in145 moroccan patients with hematologic malignancies

Diagnostic

N

Average age

Male

Female

Untreated

Treatment

ML

 AML

45

40,6 ± 16,5

24

21

32

13

 CML

10

45,4 ± 13,3

5

5

6

4

LL

 ALL

14

31,4 ± 14,8

8

6

6

8

 CLL

9

58,4 ± 16,2

6

3

4

5

 MM

18

60,3 ± 10,3

9

9

10

8

 NHL

28

51,8 ± 18,3

12

16

16

12

 HD

21

48 ± 18,2

12

9

11

10

Total

145

47,9 ± 15,3

76

69

85

60

  1. ML myeloidlineage, AML acute myeloid leukemia, CML chronic myeloid leukemia, LL lymphoidlineage, ALL acute lymphoid leukemia, CLL chronic lymphocytic leukemia, MM multiple myeloma, NHL non-Hodgkin's lymphoma, HD Hodgkin's disease
Back to article page

Clinical Proteomics

ISSN: 1559-0275